DIGITAL THERAPEUTICS:
AN OPPORTUNITY FOR ITALY, AND BEYOND
- Executive Summary
- Why a volume on digital therapeutics, and not just for Italy
- How to manage regulatory aspects for digital therapeutics
- Technical validation of digital therapeutics
- Data protection and cybersecurity in digital therapeutics
- Clinical evaluation of digital therapeutics
- Access/reimbursement policies for digital therapeutics already in use in national health systems
- Digital therapeutics, HTA and reimbursement in Italy
- Digital therapeutics, prerequisites for development of the technological and economic ecosystem in Italy and Europe
- Enabling organizational conditions for digital therapeutics in Italy
- Digital therapeutics like pharmaceuticals?
- The patient, digital health and digital therapeutics
- Digital therapeutics: ethical aspects
- Digital therapeutics in General Medicine
- Digital health, Scientific Societies and Associations of Patients & Family Members
